InspireMD to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 14, 2021

Rhea-AI Summary

InspireMD, a developer of the CGuard™ Embolic Prevention System for stroke prevention in carotid artery disease, will participate in the Benzinga Global Small Cap Conference on May 14, 2021. CEO Marvin Slosman is scheduled to present at 11:10am ET and will be available for one-on-one meetings afterward. This conference offers investors an opportunity to engage with management directly. InspireMD aims to set a new industry standard with its MicroNet® technology, promoting excellent acute results and long-term stroke-free outcomes. NSPR is the company's ticker symbol on the NYSE American.

TEL AVIV, Israel, May 06, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), announced today that management will participate at the Benzinga Global Small Cap Conference on May 14, 2021.

Chief Executive Officer Marvin Slosman will deliver his corporate presentation at 11:10am ET on May 14, 2021.

Investors can also request a one-on-one meeting with Mr. Slosman to be arranged following the conclusion of the conference.

Investors can register for the conference here:  
https://www.benzinga.com/events/small-cap/global/.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes.

InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS and NSPR.WSB.

Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com

CORE IR
investor-relations@inspiremd.com

FAQ

When will InspireMD present at the Benzinga Global Small Cap Conference?

InspireMD will present at the Benzinga Global Small Cap Conference on May 14, 2021, at 11:10am ET.

Who will present for InspireMD at the conference?

CEO Marvin Slosman will deliver the presentation for InspireMD.

How can investors meet with InspireMD's management?

Investors can request one-on-one meetings with Marvin Slosman after the conference.

What is the ticker symbol for InspireMD?

InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR.

What technology does InspireMD use for stroke prevention?

InspireMD utilizes its proprietary MicroNet® technology for the CGuard™ Embolic Prevention System.